HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Zhang Selected Research

Protein Kinase C beta

6/2009Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
3/2009Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.
8/2007Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
2/2003Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Zhang Research Topics

Disease

304Neoplasms (Cancer)
10/2022 - 01/2004
97Inflammation (Inflammations)
07/2022 - 01/2007
60Infections
06/2022 - 02/2007
49Nasopharyngeal Carcinoma
01/2022 - 09/2015
47Fibrosis (Cirrhosis)
10/2022 - 01/2003
44Neoplasm Metastasis (Metastasis)
06/2022 - 01/2015
32Type 2 Diabetes Mellitus (MODY)
11/2022 - 12/2006
31Breast Neoplasms (Breast Cancer)
09/2022 - 11/2012
31Atherosclerosis
01/2022 - 11/2005
31Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 06/2007
28Hypertension (High Blood Pressure)
06/2022 - 01/2003
26Coronary Artery Disease (Coronary Atherosclerosis)
12/2020 - 08/2011
25Allergic Rhinitis
04/2022 - 03/2009
25Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2003
24Hypoxia (Hypoxemia)
03/2022 - 01/2006
23Alzheimer Disease (Alzheimer's Disease)
10/2022 - 05/2009
23Obesity
01/2022 - 12/2008
23Body Weight (Weight, Body)
01/2022 - 03/2004
23Ischemia
01/2022 - 11/2002
23Carcinogenesis
01/2022 - 05/2008
22Hypersensitivity (Allergy)
10/2022 - 11/2009
22Lung Neoplasms (Lung Cancer)
09/2022 - 04/2010
22Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2022 - 05/2015
22Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2004
22Stroke (Strokes)
12/2021 - 04/2002
20Wounds and Injuries (Trauma)
09/2022 - 06/2007
20Ischemic Stroke
07/2022 - 10/2015
20Pain (Aches)
01/2022 - 09/2007
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 04/2011
19COVID-19
03/2022 - 01/2020
19Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2011
19Insulin Resistance
12/2021 - 01/2011
18Lung Injury
09/2022 - 01/2011
17Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 02/2012
16Autoimmune Diseases (Autoimmune Disease)
12/2022 - 01/2012
16Cognitive Dysfunction
11/2022 - 01/2014
16Myocardial Infarction
01/2022 - 08/2005
16Carcinoma (Carcinomatosis)
01/2022 - 01/2004
15Neuroinflammatory Diseases
12/2022 - 02/2016
15Heart Failure
10/2022 - 08/2005
15Infarction (Infarctions)
10/2021 - 04/2002
15Tuberculosis (Tuberculoses)
01/2021 - 01/2011
14Sepsis (Septicemia)
09/2022 - 11/2016
14Demyelinating Diseases (Demyelinating Disease)
03/2022 - 11/2015
14Asthma (Bronchial Asthma)
12/2021 - 07/2007
13Mitochondrial Diseases (Mitochondrial Disease)
09/2022 - 08/2012
13Melanoma (Melanoma, Malignant)
06/2022 - 01/2005
13Multiple Sclerosis
02/2022 - 05/2015
12Leukemia
10/2022 - 12/2002
12Acute Lung Injury
09/2022 - 01/2013
12Hypertrophy
12/2021 - 08/2004
12Proteinuria
10/2021 - 10/2004
12Lymphatic Metastasis
09/2021 - 05/2011
12Hemorrhage
03/2021 - 06/2007
11Hyperglycemia
11/2022 - 02/2003

Drug/Important Bio-Agent (IBA)

165Proteins (Proteins, Gene)FDA Link
10/2022 - 06/2005
78Biomarkers (Surrogate Marker)IBA
10/2022 - 09/2009
77Pharmaceutical PreparationsIBA
10/2022 - 01/2003
58MicroRNAs (MicroRNA)IBA
03/2022 - 01/2013
51Messenger RNA (mRNA)IBA
05/2022 - 02/2003
42CytokinesIBA
01/2022 - 07/2008
40Glucose (Dextrose)FDA LinkGeneric
11/2022 - 01/2006
40DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2005
38Long Noncoding RNAIBA
09/2022 - 01/2016
36Biological ProductsIBA
06/2022 - 11/2004
34Therapeutic UsesIBA
12/2022 - 08/2005
31EnzymesIBA
01/2022 - 12/2002
28Small Interfering RNA (siRNA)IBA
02/2022 - 07/2006
27LipidsIBA
01/2022 - 08/2006
26RNA (Ribonucleic Acid)IBA
01/2022 - 01/2003
24Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 08/2007
24Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2012
23Interleukin-6 (Interleukin 6)IBA
03/2022 - 02/2009
21Circular RNAIBA
03/2022 - 01/2017
19CholesterolIBA
01/2022 - 02/2009
18LipopolysaccharidesIBA
07/2022 - 02/2009
18Oxygen (Dioxygen)IBA
01/2022 - 01/2013
18Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 04/2009
18Insulin (Novolin)FDA Link
01/2021 - 10/2009
17Transcription Factors (Transcription Factor)IBA
06/2022 - 02/2009
17Peptides (Polypeptides)IBA
01/2022 - 11/2004
16Immunoglobulin E (IgE)IBA
06/2022 - 10/2007
15Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 03/2006
15CollagenIBA
01/2020 - 01/2006
14AntioxidantsIBA
01/2021 - 08/2006
14Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 02/2011
13ChemokinesIBA
12/2021 - 01/2007
13CalciumIBA
10/2021 - 03/2007
13Transforming Growth Factor beta (TGF-beta)IBA
01/2020 - 01/2003
12Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 01/2015
12AllergensIBA
06/2022 - 11/2009
12AntigensIBA
03/2022 - 07/2006

Therapy/Procedure

174Therapeutics
10/2022 - 01/2004
41Drug Therapy (Chemotherapy)
06/2022 - 01/2003
25Immunotherapy
10/2022 - 01/2010
24Radiotherapy
09/2021 - 01/2014
20Induction Chemotherapy
01/2022 - 10/2015
18Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2019 - 09/2015
14Chemoradiotherapy
01/2022 - 01/2014
12Hematopoietic Stem Cell Transplantation
08/2019 - 06/2011